Top Markets
Coin of the day
Minerva Surgical, Inc. Minerva Surgical, Inc.

Minerva Surgical, Inc.

UTRS
Rankning i aktier #42552
Minerva Surgical, Inc. functions as a commercial-stage medical technology... Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$888.00
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Minerva Surgical, Inc. (UTRS)

Kategori

Vinst för Minerva Surgical, Inc. (UTRS)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Minerva Surgical, Inc. är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Minerva Surgical, Inc. från 2026 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
Inte tillräckligt med data för de angivna datumen.
Vinst för liknande företag eller konkurrenter